Clinical Case Reports (May 2021)

Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction

  • Yusuke Nakano,
  • Hirohiko Ando,
  • Wataru Suzuki,
  • Hirofumi Ohashi,
  • Yasushi Suzuki,
  • Hiroaki Takashima,
  • Tetsuya Amano

DOI
https://doi.org/10.1002/ccr3.4133
Journal volume & issue
Vol. 9, no. 5
pp. n/a – n/a

Abstract

Read online

Key Clinical Message In cases of decompensated heart failure related to cancer therapy‐related cardiac dysfunction, ivabradine administration could lead to an increased stroke volume by reducing the sinus heart rate, resulting in favorable hemodynamics. Assessment of the overlap between the E‐ and A‐waves facilitates understanding the effects of ivabradine in such cases.

Keywords